Abstract
Aims & Objectives: As part of the implementation of National plan for the eradication of poliomyelitis, disease surveillance and management of cases of AAFP are key strategies of this program. The aim is participation in the national program for poliomyelitis, eradication and to determine the efficacy of intravenous immunoglobulin (IG) for treatment of AAFP Methods: From the 01 September 1994 to the 01 june 2020, 251 cases of AAFP were identified and supported in our PICU. The parameter studied were: age, gender, immunoglobulin therapy, autonomic disorders, albuminocytologic dissociation after lumbar puncture, artificial ventilation, average time of stay, and mortality Results: In this series, no case of poliomyelitis has been diagnosed by the Pasteur Institute of Algeria. Since 2008, use of IG seems to improve the mortality, 4% in the group treated with immunoglobulins series (n =93) vs 10% in the group without immunoglobulins series (n = 158), the use of mechanical ventilation appears to be reduced in the group treated with immunoglobulins. All deaths are related to the existence of severe neurovegetative disorders. Conclusions: The eradication of poliomyelitis is a national goal to declare the Algeria zone free of polio by the WHO.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
